 Enalapril proteinuria membranous glomerulonephritis detriment renal hemodynamics effect enalapril renal hemodynamics glomerular permselectivity patients nephrotic syndrome secondary biopsy-proven membranous glomerulonephritis patients drug incremental doses median mg urinary protein excretion Median treatment duration weeks Patients times run-in period II final day treatment III wash-out Median urinary protein excretion treatment g/d g/d pretreatment levels drug changes Fractional clearance dextrans nm treatment reduction macromolecules shunt pathway glomerular basement membrane GBM possible decrease ultrafiltration coefficient significant changes glomerular filtration rate GFR effective renal plasma flow ERPF mean arterial blood pressure MAP study effect enalapril proteinuria due specific intraglomerular action